Foligraf 150iu

What is Foligraf 150 IU?

Foligraf 150 IU is a generic term for a drug that has Follitropin alfa it is a recombinant version of Follicle-stimulating hormone (FSH) “150 IU” refers to the International Units of FSH activity inside the vial or in the dose.

Follitropin alfa glycoprotein hormone plays a vital function in the control of reproductive functions, specifically for women who undergo fertility treatments.

Composition

• e Ingredient:Activ Follitropin alfa (150 International Units per vial or per dose)
• Formulation: Typically, it’s an injectable sterile powder that must be reconstituted using a solvent before use.

Mechanism of Action

Follitropin alfa is a natural hormone that stimulates follicles released from the pituitary glands anterior lobe. Its principal functions are:

• Inducing the maturation and growth of ovarian follicles during women’s reproductive years.
• Promoting spermatogenesis in men.

For women who undergo assisted reproduction technology (ART) techniques such as in vitro fertilization (IVF) , Foligraf 150 IU is utilized to stimulate the growth of multiple follicles in order to improve chances of successful fertilization and ovulation.

Uses and Indications

Foligraf 150 IU is mostly recommended for fertility treatments, for example:

1. Controlled ovarian stimulation among women who are undergoing assisted reproductive methods (ART) like IVF as well as ICSI.
2. Treatment of anovulation or oligoovulation due to hypothalamic-pituitary insufficiency.
3. Spermatogenesis induction for men suffering from hypogonadotropic hypergonadism (off-label or in specific instances).
4. In certain cases of female infertility when an induction of ovulation is necessary.

Dosage and Administration

• Administration Route: Subcutaneous or intramuscular injection.
• Dosage: The duration and dosage will depend on each patient’s individual response, and the treatment plan will be specifically designed by the fertility doctor.
• The typical dose to start hormone stimulation of the ovaries is about 150 IU each day and is adjusted according to the ovarian response that is monitored by ultrasound as well as hormone levels.
• Foligraf can be administered regularly for a few days during the follicular portion of menstrual cycles until the proper follicular development has been attained.

Important: The dosage must be finely tuned as well as monitored by fertility professionals to minimize the risk of ovarian hyperstimulation syndrome (OHSS).

Precautions and Contraindications

Precautions:

• Foligraf can be used under the strict supervision of a medical professional.
• Controlling ovarian responses is crucial to avoid Ovarian hyperstimulation (OHSS).
• Do not recommend it for women who have Ovarian cysts (except cysts that are caused by polycystic Ovarian Syndrome).
• Check for reactions to allergens during the treatment.
• Take care when adjusting doses for women suffering from pituitary or hypothalamic conditions.

Contraindications:

• Hypersensitivity is a known complication of Follitropin alfa, or any other component of the formula.
• Primary ovarian failure.
• Tumors of the pituitary or hypothalamus.
• Instability of thyroid hormones or adrenal disorders.
• Pregnancy or breastfeeding.

Possible Side Effects

• Injection site reactions (pain, redness, swelling).
• Headach
• Abdominal pain or bloating.
• Ovarian hyperstimulation syndrome (OHSS) — Signs include severe abdominal pain, and symptoms include nausea, swelling, vomiting, and fast weight gain.
• Multiple pregnancy (twins or more) — because of the stimulation of many hair follicles.
• The mood can change, or you may feel fatigued.

Storage

• Keep refrigerated until 2-8°C (36-46°F).
• Keep your home safe from the elements and freeze.
• Reconstituted solutions should be used immediately or according to the instructions.

Summary

Foligraf 150IU (Follitropin alfa) is a recombinant, follicle-stimulating hormone that is used to stimulate an ovarian follicle to develop in women undergoing fertility treatment. It is a must to be administered with care and monitoring by fertility experts to increase the success rate and decrease risks like OHSS or multiple births.